London, 11 May 2015: Technavio, the independent tech-focused global research firm, has published a report on the global immunodiagnostics market 2015-2019, which is expected to grow at a CAGR of 6.59 % during the forecast period of 2014-2019.
“Increase in elderly population will result in a high-risk patient base, thus requiring early and more reliable diagnosis. About two billion people worldwide are estimated to be aged 60 and above by 2050, with more than 22% of the population being aged above 65 by 2030.”
“Increased numbers of consumers are opting for semi-automated and highly automated systems over conventional (manual) systems, which is expected to dice the market growth during the forecast period,” says Faisal Ghaus, Vice President of Technavio.
“Vendors are developing devices and systems that can help integrate various laboratory applications, which will help enhance efficiency and accessibility.”
Key Market Drivers
- Increase in Elderly Population
- High Prevalence of Chronic Diseases and Infections
- Early Diagnosis and Preventive Medicine
- Growing Focus on Emerging Economies
Key Market Trends
- Automation and System Integration
- Increased Usage of POC Diagnostic Tests
- High Demand For Biomarker-based Tests
- Growing Usage of Multiplex Bead-based Immunoassays
Key Market Vendors
- Abbott Diagnostics
- Beckman Coulter Diagnostics
- Roche Diagnostics
- Siemens Healthcare Diagnostics
To define the market circumstances in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
